Peptide Purity: Proven Guide to Reading a COA 2026

Reviewed by

Brandon Johnson — Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant

Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness. He reviews all PSPeptides educational content for scientific accuracy and practical relevance.

Peptide purity is the single most important quality metric when evaluating research compounds. Understanding what the number means, how it is measured, and how to read a COA to verify it can be the difference between reliable experimental data and confounded results. A Certificate of Analysis is the only objective evidence that what is on the label matches what is in the vial — and most buyers never read one. Many vendors count on that. Spotting a fake or doctored COA is one of the clearest defenses covered in how to avoid peptide scams. This guide walks through the analytical framework used to determine peptide quality, how to read a COA line by line, and the red flags researchers should recognize before ordering.

After the Peptide Sciences shutdown, Paradigm Peptides’ federal charges (products contained testosterone instead of the labeled compounds), and FDA enforcement actions across the industry, the ability to evaluate a certificate of analysis is no longer optional for serious researchers. Vendor selection frameworks including the how to choose a research peptide supplier guide place COA transparency and documentation depth at the center of the evaluation.

Table of Contents

What “Purity” Actually Means in Peptide Research

Purity refers to the percentage of the total sample that consists of the target compound versus impurities. A product sold at 99% peptide purity means that 99% of the material in the vial is the intended peptide, and 1% consists of other substances — synthesis byproducts, degradation products, residual solvents, or truncated sequences.

The remaining impurities matter because they can interfere with experimental results (confounding variables), cause unexpected biological effects (off-target activity), or indicate poor manufacturing quality (suggesting potential issues with identity, stability, or sterility). Researchers working with low-quality samples may observe inconsistent dose-response curves, failed replication, or unexpected biological effects that are actually caused by contaminants rather than the target compound.

Why 99%+ Is the Research Standard

Different purity grades serve different purposes in laboratory research:

99%+

Research grade — pharmaceutical-quality standard

Serious quantitative research protocols

95-98%

Preliminary research quality

Screening studies, preliminary work

<95%

Below research standards

Not recommended for reproducible work

The pharmaceutical-quality 99%+ threshold has become the industry-standard peptide quality baseline because impurities below 1% are statistically negligible in most experimental designs. Anything below 98% introduces enough impurity mass to potentially affect dose-response relationships and experimental outcomes. Reputable vendors publish COAs demonstrating 99%+ verification via both HPLC and Mass Spectrometry on every batch.

The Two Essential Tests: HPLC and Mass Spectrometry

HPLC (High-Performance Liquid Chromatography)

HPLC peptide testing separates the components of a sample based on their chemical properties — polarity, hydrophobicity, and molecular size. The target peptide appears as a distinct peak in the resulting chromatogram, and the area under that peak relative to all other peaks in the chromatogram gives the purity percentage.

A well-conducted HPLC analysis for peptides uses reverse-phase columns with C18 stationary phases and gradient elution with acetonitrile-water mobile phases containing 0.1% trifluoroacetic acid (TFA). Detection is typically UV absorbance at 214 nm (peptide bond absorption) or 220-280 nm for peptides containing aromatic residues. The result appears on a certificate of analysis as a numerical percentage (e.g., “99.4% purity by HPLC”) accompanied by the chromatogram itself showing the target peak and any impurity peaks.

Column specifications, mobile phase composition, gradient program, and detection wavelength should all be disclosed on a professional COA. The absence of these methodological details is itself a warning sign about documentation depth. Published guidance on peptide purity analysis from the pharmaceutical industry is available in the Journal of Pharmaceutical and Biomedical Analysis.

Mass Spectrometry (MS) — Confirming Identity

Mass Spectrometry answers a different question than HPLC. Where HPLC quantifies the percentage of target compound versus impurities, Mass Spectrometry verifies the molecular identity — confirming that the compound in the vial actually is the peptide claimed on the label. HPLC alone can confirm a purity percentage but cannot confirm identity: a sample could test at 99% on HPLC and still be the wrong compound entirely.

Mass Spectrometry works by ionizing the sample and measuring the mass-to-charge ratio of the resulting ions. For peptides, the observed mass is compared to the theoretical mass calculated from the amino acid sequence — a match within a few daltons confirms molecular identity. Techniques include ESI-MS (electrospray ionization) and MALDI-TOF (matrix-assisted laser desorption-time of flight), both of which appear on COA documentation with the observed and theoretical mass values.

The Paradigm Peptides federal case demonstrated exactly why Mass Spectrometry matters. Their products showed high chromatographic purity, but the compound was not what was labeled on the vial. Only Mass Spectrometry verification catches this failure mode. A COA missing Mass Spectrometry data leaves an open question about identity that HPLC alone cannot answer.

How to Read a COA Step by Step

Once a COA is in hand, evaluating it is a systematic process. The following five checkpoints separate legitimate documentation from marketing filler.

Step 1: Verify It Is Batch-Specific

Every COA should include a batch or lot number that matches the vial you received. A “sample COA” or “typical result” document is not sufficient — it does not prove anything about the specific product in your possession. Batch-specific documentation is the minimum standard for meaningful COA evaluation.

Step 2: Check for Both HPLC and Mass Spec

A complete peptide COA includes both an HPLC purity result and a Mass Spectrometry identity confirmation. If only HPLC data is present, the certificate of analysis provides quantitative purity but no identity verification. If only MS data is present, identity is confirmed but the purity percentage is not documented. Both are required for full quality assurance.

Step 3: Verify Purity ≥99%

The stated peptide purity should be 99% or higher for pharmaceutical-quality research standards. Numbers between 95-98% may be acceptable for screening studies but are inadequate for quantitative dose-response work or publication-grade research. Below 95% indicates a product that should not be used for reproducible research.

Step 4: Confirm Molecular Weight Match

The observed mass from Mass Spectrometry should match the theoretical mass calculated from the target peptide’s amino acid sequence, within acceptable analytical error. Discrepancies of more than a few daltons indicate identity problems — the compound may not be what the label says.

Step 5: Check the Testing Methodology

Legitimate COAs disclose analytical method details: HPLC column type, mobile phase composition, gradient program, detection wavelength, mass spectrometry ionization mode. This disclosure allows the results to be reproduced in principle and demonstrates the vendor understands their own testing. Missing methodology is a red flag about documentation depth, regardless of the numerical values reported.

Peer-Reviewed Evidence on Purity and Reproducibility

Peer-reviewed publications increasingly document the importance of peptide quality documentation for research reproducibility. Research published in Analytical Chemistry demonstrates that peptide impurity profiles can introduce biological confounds that alter experimental outcomes independent of the target compound’s actual activity, particularly in receptor-binding assays where micromolar impurities of related-sequence peptides can compete for binding sites.

The Journal of Peptide Science has published methodology papers establishing the analytical standards researchers should expect from commercial peptide suppliers, including recommended purity thresholds, required identity confirmation methods, and reporting standards for COA documentation. These standards align with the 99%+ threshold and dual HPLC/MS verification framework used by pharmaceutical peptide manufacturers.

Research reproducibility is directly tied to compound quality consistency across batches. If two researchers use peptides from different batches with different actual purity levels (even if both are labeled 99%), their results may diverge significantly. Published research standards increasingly require documentation of peptide quality as part of methodology sections in journal submissions.

Red Flags in COA Documentation

Several documentation patterns should immediately raise concerns during vendor evaluation.

“Sample” or “typical” COAs. If the certificate of analysis provided is not batch-specific, it proves nothing about the actual product being sold. This is one of the most common documentation shortcuts used by vendors who do not conduct testing on every batch.

HPLC only, no Mass Spectrometry. As demonstrated by the Paradigm Peptides case, HPLC alone cannot verify identity. A COA missing MS data leaves the identity question open and should be treated with skepticism regardless of the reported purity percentage.

Missing methodology details. Legitimate testing discloses the analytical method used. COAs that report only numerical results without column, mobile phase, or ionization method suggest the vendor either did not conduct the testing themselves or does not understand the methodology well enough to disclose it.

Testing by an unnamed lab. Third-party testing should identify the laboratory that conducted the analysis. Unnamed “third-party lab” language without a specific accredited laboratory identified is not verifiable and does not meet the standard for independent verification.

In-house testing only, without accredited third-party verification. A vendor grading their own product is a significant conflict of interest. Testing conducted under ISO 17025 or equivalent accreditation provides objective data that cannot be influenced by commercial interests.

Purity vs. Other Peptide Quality Metrics

Peptide quality involves multiple parameters beyond the purity percentage. A complete quality picture includes several complementary measurements:

Chromatographic purity

Percentage of target compound vs impurities

Primary quality metric

Molecular identity

Confirmed molecular weight matches theoretical

Verifies it is the labeled compound

Peptide content

Actual peptide mass vs total powder mass

Salt/water content affects dosing calculations

Endotoxin level

Bacterial contamination measurement

Important for cell-based and in vivo research

Sterility testing

Absence of viable microorganisms

Critical for injectable research use

A comprehensive COA addresses all of these parameters, not just chromatographic purity. Vendors that limit their reporting to a single number without addressing identity, content, or contamination provide an incomplete quality picture.

How Storage Conditions Affect Purity After Receipt

Even peptides that arrive at 99%+ purity can degrade after receipt if storage conditions are inadequate. Lyophilized peptides are relatively stable at -20°C in sealed containers protected from light, but temperature excursions, moisture exposure, and repeated freeze-thaw cycles accelerate degradation.

Once reconstituted with bacteriostatic water or another diluent, degradation kinetics reactivate. Reconstituted peptides typically maintain acceptable stability for approximately 28 days at 2-8°C, though this varies by peptide chemistry. Peptides with disulfide bonds, free thiol groups, or oxidation-sensitive residues have shorter stability windows in solution. For complete storage protocol guidance, see the peptide storage guide. For reconstitution methodology that preserves purity through the dissolution process, see the peptide reconstitution guide.

PSPeptides Analytical Standards

Every PSPeptides product undergoes analytical testing via both HPLC and Mass Spectrometry before release. Results confirm 99%+ purity with molecular identity verification on every batch. COAs are batch-specific, publicly accessible on the certifications page, and include full method details — column specifications, mobile phase composition, gradient program, detection wavelength, and MS ionization mode — meeting the documentation depth criteria outlined earlier in this guide. For a criterion-by-criterion vendor comparison including COA transparency, see the best peptide companies 2026 ranking.

View PSPeptides Certificates of Analysis → | Browse Research Peptides →

Frequently Asked Questions

What does 99% peptide purity actually mean?

A reading of 99% peptide purity means that 99% of the material in the vial is the target compound, and 1% consists of synthesis byproducts, degradation products, truncated sequences, or residual solvents. This is the minimum threshold considered research grade because impurities below 1% are statistically negligible in most experimental designs. Anything below 98% introduces enough impurity mass to potentially affect dose-response relationships and experimental outcomes.

Can I trust a COA from the same company that made the peptide?

In-house COAs without accredited verification represent a significant conflict of interest — the vendor is grading their own product. Testing conducted under ISO 17025 or equivalent accreditation provides objective data that cannot be influenced by commercial interests. A complete certificate of analysis peptides researchers should trust discloses the analytical methodology in full, including column, mobile phase, detection wavelength, and mass spectrometry parameters, so that the results could in principle be reproduced.

Why do some vendors claim high purity without Mass Spectrometry?

HPLC peptide testing alone can confirm a purity percentage but cannot confirm the compound’s identity. A sample could test at 99% on HPLC and still be the wrong compound entirely — chromatography would not detect this. Mass Spectrometry is essential because it confirms the molecular weight matches the target peptide. The Paradigm Peptides case demonstrated exactly this failure: their products showed high chromatographic purity, but the compound was not what was labeled on the vial.

How does peptide purity affect research reproducibility?

Research reproducibility is directly tied to compound quality consistency. If two researchers use peptides from different batches with different actual purity levels (even if both are labeled 99%), their results may diverge significantly. Published research standards increasingly require documentation of peptide quality as part of methodology sections. Using verified 99%+ compounds from batch-specific COAs provides a documented quality baseline that supports reproducible, publishable results.

All PSPeptides products are sold exclusively for research and laboratory use.